Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Annals of Biomedical Engineering

Quantum Machine Learning for Biomedical Classification Problems: A Feasibility Study on Real Quantum Hardware

Hongbin Liu, Zhemin Zhang, Kangyu Zheng, Zhiding Liang, Chi-Sheng Chen, Christopher Carothers, Juergen Hahn

Published May 28, 2026• 1 citation
Publisher
DOI
10.1007/s10439-026-04204-8

Related papers

Quantum Machine Learning (QML) Algorithms for Smart Biomedical Applications

Inzimam Ul Hassan Swati, Aakansha Khanna

QML, short for quantum machine learning, is experiencing rapid growth as it combines the power of quantum computers with machine learning methods to enhance pattern identification and prediction. QML has demonstrated significant promise in biomedical research, since it has been used for the analysis of massive data sets from diverse sources, such as proteomics, genomics, and medical imaging. This chapter gives a broad overview of QML’s present status in biomedical applications, including both the theoretical underpinnings of the language and real-world implementations. First, we go over the fundamental ideas of quantum computing and machine learning, such as quantum gates, quantum circuits, and traditional machine learning techniques. The main difficulties in applying QML to biomedical applications are then discussed, including handling noisy quantum hardware and creating effective quantum algorithms for large, complicated data sets. We also go over some of the most exciting directions for this field’s research, such as the use of QML for illness diagnostics, personalized medicine, and drug development. In conclusion, we offer an array of case examples that demonstrate QML’s potential for use in biomedical research. These case studies address a variety of subjects, such as identifying protein-ligand binding affinities and using medical picture analysis to diagnose cancer. All things considered, this chapter offers a thorough review of QML’s current status in biomedical research, stressing both its promise and the obstacles that must be removed in order to fully realize it.

CRC Press eBooks•Feb 21, 2025•1 citation

A Quantum Machine Learning Model for Medical Data Classification

Hamza Kamel Ahmed, Baraa Tantawi, Malak Magdy +1 more

Studies in computational intelligence•Jan 1, 2023•3 citations

Quantum Machine Learning Algorithms for Diagnostic Applications: A Review

Shruti S. Pophale, Amit Gadekar

Lecture notes in electrical engineering•Jan 1, 2023•3 citations

Quantum convolutional HLA immunogenic peptide prediction (Q-CHIPP): Next-generation neoantigen prediction with quantum neural network

Ryan Peters, Kahn Rhrissorrakrai, Prerana Bangalore Parthasarathy +10 more

The rapid growth of quantum computing is driven by promises of performing complex calculations with unprecedented speed; however, current use cases have been limited by quantum hardware and the difficulty of identifying problems that classical computers cannot easily address. Within these constraints, biological problems including drug discovery, protein folding, and precision medicine present an opportunity to understand how current quantum hardware can make advances. In immunology, accurate prediction of cancer neoantigens remains a major challenge, limited by small, noisy datasets and the inability of classical models to generalize. In approaching the problem, we explore multiple noise mitigation techniques, including Pauli twirling and dynamical decoupling, in conjunction with controlled shot-based sampling to stabilize training on real hardware and in a warm start hybrid approach. With these approaches, we demonstrate the use of Quantum Convolutional Neural Networks (QCNNs) for both MHC binding and immunogenicity prediction, including a quantum hardware experiment involving 46 qubits that achieved a 6% increase in classification accuracy with fewer training samples compared to classical approaches. Building on these models, we introduce Quantum Convolutional HLA Immunogenic Peptide Prediction (Q-CHIPP), a combinatorial framework integrating MHC binding and T-cell recognition. It targets HLA-A*02:01-restricted 9-mer peptides and, more accurately, identifies those peptides known to be immunogenic, improving the prognostic impact of predicted neoantigen load. Together, these represent a large-scale application of QCNNs in biomedical modeling, highlighting both the feasibility and promise of quantum machine learning for data-limited biological systems and establishing a scalable foundation for quantum-enhanced biomedical research.

Science Advances•Jul 24, 2026•0 citations

Quantum Kernel-Based Cancer Atlas: Hardware-Validated Mapping of Gene Expression to Drug Response

Gulfam Hussain

This work presents a hardware-validated quantum framework for encoding cancer gene expression data and evaluating its alignment with drug response signals. Using a quantum kernel-based architecture (Qube Engine), classical gene expression data from CCLE is transformed into quantum states and executed on IBM Quantum hardware. Outputs are compared against IC50 drug response values from the GDSC dataset. The system demonstrates strong stability under real hardware noise (~97.15%) and maintains measurable biological relevance, achieving a correlation of ~0.45 with IC50 values. This work highlights the feasibility of applying quantum machine learning techniques to real-world biomedical datasets under NISQ constraints.

•Apr 17, 2026•0 citations

Advances in Medical Image Classification Using Quantum Machine Learning: A Survey

Anisurrahman, Bashir Alam, Muhammad Hamid

Lecture notes in networks and systems•Dec 1, 2025•0 citations
QML, short for quantum machine learning, is experiencing rapid growth as it combines the power of quantum computers with machine learning methods to enhance pattern identification and prediction. QML has demonstrated significant promise in biomedical research, since it has been used for the analysis of massive data sets from diverse sources, such as proteomics, genomics, and medical imaging. This chapter gives a broad overview of QML’s present status in biomedical applications, including both the theoretical underpinnings of the language and real-world implementations. First, we go over the fundamental ideas of quantum computing and machine learning, such as quantum gates, quantum circuits, and traditional machine learning techniques. The main difficulties in applying QML to biomedical applications are then discussed, including handling noisy quantum hardware and creating effective quantum algorithms for large, complicated data sets. We also go over some of the most exciting directions for this field’s research, such as the use of QML for illness diagnostics, personalized medicine, and drug development. In conclusion, we offer an array of case examples that demonstrate QML’s potential for use in biomedical research. These case studies address a variety of subjects, such as identifying protein-ligand binding affinities and using medical picture analysis to diagnose cancer. All things considered, this chapter offers a thorough review of QML’s current status in biomedical research, stressing both its promise and the obstacles that must be removed in order to fully realize it.
The rapid growth of quantum computing is driven by promises of performing complex calculations with unprecedented speed; however, current use cases have been limited by quantum hardware and the difficulty of identifying problems that classical computers cannot easily address. Within these constraints, biological problems including drug discovery, protein folding, and precision medicine present an opportunity to understand how current quantum hardware can make advances. In immunology, accurate prediction of cancer neoantigens remains a major challenge, limited by small, noisy datasets and the inability of classical models to generalize. In approaching the problem, we explore multiple noise mitigation techniques, including Pauli twirling and dynamical decoupling, in conjunction with controlled shot-based sampling to stabilize training on real hardware and in a warm start hybrid approach. With these approaches, we demonstrate the use of Quantum Convolutional Neural Networks (QCNNs) for both MHC binding and immunogenicity prediction, including a quantum hardware experiment involving 46 qubits that achieved a 6% increase in classification accuracy with fewer training samples compared to classical approaches. Building on these models, we introduce Quantum Convolutional HLA Immunogenic Peptide Prediction (Q-CHIPP), a combinatorial framework integrating MHC binding and T-cell recognition. It targets HLA-A*02:01-restricted 9-mer peptides and, more accurately, identifies those peptides known to be immunogenic, improving the prognostic impact of predicted neoantigen load. Together, these represent a large-scale application of QCNNs in biomedical modeling, highlighting both the feasibility and promise of quantum machine learning for data-limited biological systems and establishing a scalable foundation for quantum-enhanced biomedical research.
This work presents a hardware-validated quantum framework for encoding cancer gene expression data and evaluating its alignment with drug response signals. Using a quantum kernel-based architecture (Qube Engine), classical gene expression data from CCLE is transformed into quantum states and executed on IBM Quantum hardware. Outputs are compared against IC50 drug response values from the GDSC dataset. The system demonstrates strong stability under real hardware noise (~97.15%) and maintains measurable biological relevance, achieving a correlation of ~0.45 with IC50 values. This work highlights the feasibility of applying quantum machine learning techniques to real-world biomedical datasets under NISQ constraints.